Eliem Therapeutics Long-Term Investments 2021-2024 | CLYM
Eliem Therapeutics long-term investments from 2021 to 2024. Long-term investments can be defined as the aggregate value of debt and or equity investments with maturities or benefits lasting more than one year.
Eliem Therapeutics Annual Long-Term Investments
(Millions of US $) |
| 2023 |
$ |
| 2022 |
$ |
| 2021 |
$25 |
| 2020 |
$ |
Eliem Therapeutics Quarterly Long-Term Investments
(Millions of US $) |
| 2024-06-30 |
|
| 2024-03-31 |
|
| 2023-12-31 |
|
| 2023-09-30 |
|
| 2023-06-30 |
|
| 2023-03-31 |
|
| 2022-12-31 |
|
| 2022-09-30 |
$7 |
| 2022-06-30 |
$12 |
| 2022-03-31 |
$26 |
| 2021-12-31 |
$25 |
| 2021-09-30 |
$24 |
| 2021-06-30 |
|
| 2021-03-31 |
|
| 2020-12-31 |
|
| 2020-09-30 |
|
| 2020-06-30 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-DRUGS |
$0.342B |
$0.000B |
|
Eliem Therapeutics Inc. is a clinical-stage biotechnology company. It focused on developing novel therapies for neuronal excitability disorders to address unmet needs in chronic pain, psychiatry, epilepsy and other disorders of the peripheral and central nervous systems. Eliem Therapeutics Inc. is based in SEATTLE, United Kingdom.
|
